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Prevalence and correlates for ADHD
and relation with social and academic
functioning among children and
adolescents with HIV/AIDS in Uganda
Richard Stephen Mpango1,2*, Eugene Kinyanda1,7, Godfrey Zari Rukundo2, Jonathan Levin3,4,
Kenneth D. Gadow5 and Vikram Patel6
Abstract
Background: Aim of this study was to determine the prevalence of attention-deficit/hyperactivity disorder (ADHD),
its associated correlates and relations with clinical and behavioural problems among children and adolescents with
HIV/AIDS (CA-HIV) attending five HIV clinics in central and South Western Uganda.
Methods: This study used a quantitative design that involved a random sample of 1339 children and adolescents
with HIV and their caregivers. The Participants completed an extensive battery of measures including a standardized
DSM-5 referenced rating scale, the parent version (5–18 years) of the Child and Adolescent Symptom Inventory-5
(CASI-5). Using logistic regression, we estimated the prevalence of ADHD and presentations, correlates and its
impact on negative clinical and behavioural factors.
Results: The overall prevalence of ADHD was 6% (n = 81; 95%CI, 4.8–7.5%). The predominantly inattentive
presentation was the most common (3.7%) whereas the combined presentation was the least prevalent (0.7%).
Several correlates were associated with ADHD: socio-demographic (age, sex and socio-economic status); caregiver
(caregiver psychological distress and marginally, caregiver educational attainment); child’s psychosocial environment
(quality of child-caregiver relationship, history of physical abuse and marginally, orphanhood); and HIV illness
parameters (marginally, CD4 counts). ADHD was associated with poor academic performance, school disciplinary
problems and early onset of sexual intercourse.
Conclusions: ADHD impacts the lives of many CA-HIV and is associated with poorer academic performance and
earlier onset of sexual intercourse. There is an urgent need to integrate the delivery of mental health services into
routine clinical care for CA-HIV in Sub-Saharan Africa.
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Background
The Joint United Nations Programme on AIDS estimates
that 88% of the global 3.3 million children and adoles-
cents living with HIV (CA-HIV) reside in Sub-Saharan
Africa [1]. Most of these CA-HIV who were perinatally
infected with HIV are at risk of developing emotional
and behavioural problems [2]. Although many countries
in Sub-Saharan Africa including Uganda [3] have
adopted the WHO policy recommendation [4] that calls
for the integration of mental health services into HIV
care, most HIV clinics on the continent have yet to
implement them [5].
In Uganda, prevalence of HIV in the general popula-
tion has stabilised around 7.4% [6], with highest rates in
the Central Region (10.6%) and the lowest in Mid-
Eastern Region (4.1%). Prevalence is higher among
women (8.3%) than men (6.1%); 3.7% of young women
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and men between 15 and 24 years of age are HIV-
positive [3]. There is fairly compelling evidence that HIV
contributes to neurocognitive impairment and possibly
neuropsychiatric illnesses [7–10]. CA-HIV experience
relatively high rates of psychopathology [11–15] that
could arise from the direct and indirect effects of HIV
including the psychosocial problems of family disrup-
tions; poor social support; and a high burden of negative
life events, stigma, poverty and chronic ill health [16]
and the burden of long-term treatment with antiretro-
viral therapy (ART) [17].
Previous studies have found that ADHD is one of the
most common psychiatric disorders among CA-HIV
(Scharko, as cited in Mellins and Malee, 2013) [2]. How-
ever, little is known about ADHD among CA-HIV in
Sub-Saharan Africa. Most of what is known comes from
two studies [15, 18] conducted in Kenya and South
Africa. The Kenyan study reported a prevalence of 12.2%
as based on both parent and youth report [18], whereas
the South African study found rates of 88% and 17%
based on parent and teacher ratings, respectively [15].
The rates of ADHD reported in the Kenyan and South
African studies differed significantly possibly due to
differences in the assessment instruments used. Whereas
the Kenyan study used the MINI International Neuro-
psychiatric Interview for children and adolescents
(MINI-KID) [18], a DSM IV based psychiatric assess-
ment tool that undertakes both a symptom count and
assessment of functional impairment, the South African
study used the Swanson, Nolan and Pelham rating scale
[15], a DSM IV-based psychiatric assessment tool that only
assesses symptom count. To date, no study has established
the prevalence of ADHD among CA-HIV in Uganda.
Although it is widely recognized that ADHD is highly
heritable [19], a wide range of variables are associated
with symptom severity in CA-HIV [2], and these include
impaired social and academic functioning [2, 17, 20–24],
which can negatively affect quality of life. However,
relatively little is known about child, family, and illness
characteristics associated with severity of ADHD among
CA-HIV in East Africa or their implications for func-
tional outcomes. The primary objectives of the present
study were to (a) document the prevalence of ADHD
among a large sample of CA-HIV attending rural and
urban HIV clinics in Uganda, (b) characterize the re-
lation of ADHD severity with a wide range of com-
monly studied clinical correlates, and (c) examine the
relation of ADHD with important indices of academic
and social functioning. We were particularly inter-
ested in ADHD because it is associated with emo-
tional and behavioural dysregulation thus increasing
the risk of impaired decision making, poor impulse
control, risky sexual behaviour, and aggression among
CA-HIV [2].
Methods
Participants
The study comprised a random sample of 1339 child/
adolescent-caregiver dyads from the five HIV clinics in
rural (Masaka) and urban (Kampala) Uganda. To be
eligible for the study, CA-HIV had to be between 5 and
11 and 12–17 years of age, respectively, and caregivers
had to be at least 17 years of age. Both CA-HIV and
caregivers had to speak English or Luganda (the local
language spoken in the study areas) and plan to reside in
the study area for the subsequent 12 months. Exclusion
criteria were concurrent enrollment in another study
(which applied to only one site), need of immediate
medical attention, and unable to understand the study’s
assessment instruments.
Measures
The assessment battery comprised standardised, locally
translated psychosocial instruments [16, 17, 25–35].
Study variables reported in this paper are described in
Additional file 1: Table S1 arranged according to the
conceptual framework. ADHD was established using a
clinically practical, DSM-5-referenced, behaviour rating
scale, the Child and Adolescent Symptom Inventory-5
(CASI-5) [34], which was previously used to study
ADHD in CA-HIV in the United States [35, 36]. CASI-5
items can be scored in several different ways, and in the
present study we used the symptom count cut-off score.
Symptom count cut-off score indicates whether child/
adolescent has the prerequisite number of symptoms
necessary for a DSM-5 diagnosis. The CASI-5 also
provides an algorithm that we used to generate the
different ADHD presentations.
Procedures
To obtain the required sample of 268 study participants
per study site, research assistants identified potential
participants from the patient register. Those who met
eligibility criteria were then invited to enroll into the
study. This procedure was repeated each clinic day until
the required sample size of each site was attained. About
2% of eligible participants were not included owing to a
number of reasons including participation in another
ongoing study, inability to contact the caregiver to ob-
tain consent, or refusal to give consent by the caregiver.
The study protocol was administered by trained psychi-
atric nurses and psychiatric clinical officers supervised by a
clinical psychologist (RM) and overseen by a psychiatrist
(EK). Interviews were conducted in two parts, each part
lasting 30 min with a tea break in between. Psychosocial
assessments used for the first time in Ugandan, which in-
cluded the CASI-5 [34], underwent a translation and local
adaptation process described in a separate paper [37].
Briefly, this entailed separate forward and back translations
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by teams of mental health professionals and lay people
conversant in both English and Luganda; a consensus
workshop of translation teams to derive the versions with
the most acceptable face validity; and administration to
CA-HIV/caregiver dyads to refine the terminology in order
to enhance clarity.
Statistical analyses
Prevalence of the three ADHD presentations (predomin-
antly inattentive, predominantly hyperactive-impulsive,
and combined) as well as any ADHD was estimated with
95% confidence intervals by age-group and gender. Clin-
ical correlates for ADHD were determined by fitting
multiple logistic regression models, using the approach
recommended by Victora et al. [38]. These variables
were divided into four groups: socio-demographic, care-
giver, child’s psychosocial environment, and CA-HIV
health status (see Fig. 1). First, an initial prediction
model was selected based only on socio-demographic
variables; study site (as a design variable), sex and age
were included in all models as a priori confounders,
while other socio-demographic variables were excluded
from the model if they were not significant at the 10%
level. Caregiver characteristics were then added to the
socio-demographic model that had been selected, and
those variables that were not statistically significant at the
10% level were removed. Next, psychosocial environment
variables were then added to the socio-demographic and
caregiver model, and variables that were not statistically
significant at the 10% level were removed. Analyses were
conducted separately for children and adolescents as some
variables were obtained for adolescents but not on
children. Then, variables related to the health status of
CA-HIV were added to the previous model, and those that
were not significant at the 10% level were removed.
Finally, any of the initial variables that were no longer sig-
nificant at the 15% level were omitted. This liberal p-value
for potential confounders is advocated by some experts,
e.g., Royston et al. [1].
We then examined the association of ADHD with sev-
eral functional outcomes: poor academic performance at
school, poor social functioning at school (experienced
problems at school), number of visits to the health unit in
the past month, hospital admissions in the last month,
non-adherence to HIV treatment and risky sexual behav-
iour (onset of sexual intercourse) (see Additional file 1 for
Fig. 1 Conceptual framework for clinical correlates of ADHD
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a detailed description of these variables). For each of these
outcomes, the association with ADHD was assessed by
fitting a logistic regression model, adjusting for study site
(as a design variable), sex, age and educational level. For
visit to a health unit and hospital admission, adjustment
was also made for current CD4 count, whereas for
adherence, adjustment was made for whether or not
the CA-HIV was receiving ART (which determined
how non-adherence was measured). Associations were
assessed separately for each ADHD presentation.
To adjust for multiple testing we followed the sugges-
tion of Bender and Lange [37] and regarded the study as
an exploratory study in which significance tests were used
for descriptive purposes rather than for decision making.
Thus, findings should be viewed as preliminary, and fur-
ther work is required to carry out confirmatory studies.
This approach is supported by Vittinghoff et al. [39] who
noted that in an exploratory analysis, it is not clear how
many comparisons should be corrected for, but stressed
the need for cautious interpretation of any findings.
Ethical considerations
The study obtained ethical approvals from the Uganda
Virus Research Institute’s Research and Ethics Commit-
tee, the Ethics Committee of the London School of Hy-
giene and Tropical Medicine and the Uganda National
Council of Science and Technology. Participants volun-
tarily provided consent (caregivers)/assent (CA-HIV).
Participants found to have a psychiatric disorder were
provided with psycho-education and referred to their
local mental health departments.
Result
Characteristics of study participants
Briefly, 64% of CA-HIV were between 5 and 11 years,
and 36% were between 12 and 17 years (see Additional
file 2 for a detailed description of the study sample). The
urban and rural study sites contributed equally. There
slightly were more females (52%) than males (48%). With
regard to HIV illness parameters, 88% had CD4 counts
equal or greater than 350 cells/μL, and most (95%) of
the participants were receiving ART.
Prevalence of ADHD
Six percent (6.0%; 95% CI, 4.8–7.5%) of CA-HIV met
CASI-5 symptom count criteria for at least one ADHD
presentation (Table 1). For specific presentations, rates
were 3.7% for the predominantly inattentive (I) presenta-
tion, 1.6% for the predominantly hyperactive-impulsive
(HI) presentation, and 0.7% for the combined (C) pres-
entation. Among children the most frequent ADHD
presentation was ADHD-I (3.0%), followed by ADHD-
HI (2.0%) with ADHD-C (0.6%) being the least frequent.
Among adolescents ADHD-I (4.8%) was also the most
frequent, but both ADHD-HI (1.0%) and ADHD-C
(1.0%) were second. The rank order of presentations was
the same for both males and females.
Clinical correlates of ADHD inattentive
Variables associated with ADHD-I symptom count cut-
off score were increasing age (aOR of 1.14 per 1 year
increase in age, p = 0.004), socio-economic status (aOR
of 1.91 per unit increase in SES, p = 0.009), caregiver
psychological distress scores (aOR of 1.11 per unit in-
crease in psychological distress scores of caregiver,
p = 0.004), and quality of child-caregiver relationship
(aOR of 1.34 per unit deterioration in quality of the child-
caregiver relationship scores, p < 0.0001) (see Additional
file 3). Higher caregiver educational status (p = 0.08) and
CD4 counts (p = 0.06) approached significance.
Clinical correlates of ADHD hyperactive-impulsive
Variables associated with ADHD-HI symptom scores
were increasing caregiver psychological distress scores
(aOR of 1.11 per unit increase in psychological distress
scores of caregiver, p = 0.02), quality of child-caregiver
relationship (aOR of 1.20 per unit deterioration in qual-
ity of the child-caregiver relationship scores, p = 0.09),
and only assessed among adolescents, having ever been
beaten (aOR = 5.0, p = 0.02) (see Additional file 3).
Clinical correlates of ADHD combined
Variables associated with ADHD-C symptom scores
were caregiver psychological distress (aOR of 1.16 per
unit increase in psychological distress scores of caregiver,
Table 1 The prevalence of ADHD based on CASI-5 Symptom Count Cut-off scores
ADHD-I ADHD-HI ADHD-C Any ADHD
Subgroup N n (%) n (%) n (%) n (%)
Symptom Count Cut-off 1339 49(3.7%) 22 (1.6%) 10 (0.7%) 81 (6.0%)
Children 860 26 (3.0%) 17 (2.0%) 5 (0.6%) 48 (5.6%)
Adolescents 479 23 (4.8%) 5 (1.0%) 5 (1.0%) 33(6.9%)
Male 638 30 (4.7%) 13 (2.0%) 6 (0.9%) 49(7.7%)
Female 699 19 (2.7%) 9 (1.3%) 4 (0.6%) 32(4.6%)
NOTE: ADHDattention-deficit/hyperactivity disorder, I inattentive presentation, HI hyperactive-impulsive presentation, C combined presentation, CASI Child and
Adolescent Symptom Inventory
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p = 0.04) (see Additional file 3). Orphanhood was mar-
ginally significant (p = 0.05), with rates highest for those
CA-HIV with no living parent compared to those who
had at least one living parent (aOR = 11.03, p = 0.05).
Clinical correlates of any ADHD
Variables associated with having any ADHD presentation
were increasing socio-economic status (aOR of 1.84 per
unit increase in SES, p = 0.004), caregiver psychological
distress scores (aOR of 1.11 per unit increase in psycho-
logical distress scores of caregiver, p = 0.001), quality of
child-caregiver relationship (aOR of 1.32 per unit deteri-
oration in quality of the child-caregiver relationship
score, p < 0.0001) (see Additional file 3). Caregiver
educational level was marginally significant (p = 0.06).
Association between ADHD presentation and outcome
ADHD-I presentation and having any ADHD were asso-
ciated with poor academic performance (see Table 2),
and having any ADHD was associated with having prob-
lems at school. ADHD-I and having any ADHD were mar-
ginally associated with early initiation of sexual intercourse
(p = 0.07). None of the ADHD presentations were associ-
ated with non-adherence to HIV treatment, number of
hospital visits, or number of hospital admissions.
Discussion
This study aimed to determine the prevalence of ADHD
among CA-HIV in Uganda and associations of ADHD
with commonly studied mental health clinical correlates
and social, academic and clinical functioning. The preva-
lence of caregiver-rated ADHD was 6%, which is similar
to caregiver-reported CASI ADHD rates for non-HIV,
community-based samples in the United States [40, 41].
When we adopted a more clinically oriented criterion
for any ADHD based on both symptom count cut-off
score and impairment cut-off score, the prevalence of
any ADHD was 2.2%, which underscores the importance
of considering criteria for defining ADHD when com-
paring results across studies. With regard to CA-HIV, a
study conducted in the United States that used CASI
[17, 35] symptom count cut-off scores found that 16%
met criteria for ADHD according to caregiver ratings
[36]. These findings seem to suggest that the rate of
ADHD in the United States study is much higher than
that in Uganda, at least among HIV populations. How-
ever, Gadow et al. [17] also found the prevalence of
ADHD among uninfected youth in the United States
from HIV-affected families was similar to CA-HIV
(12.6%), and rates for both groups (infected and affected)
were higher than comparable rates for population-based
samples [40, 41]. The authors noted that one plausible ex-
planation for these differences between infected/affected
youth and population-based samples in the United States
is the much higher percentage of minority youth among
the former and the well-established relation of minority
status with mental health concerns, clinical correlates, and
less than optimal health care. To this we would add that
socio-cultural differences in symptom grading among
caregivers in more industrialised Western countries as
compared to the more agrarian Ugandan environment
(where the caregivers are expected to have a tolerance for
psychiatric symptomatology as compared to their Western
counterparts) may also contribute to disparate rates of
ADHD.
In Uganda the most common ADHD presentation was
ADHD-I, followed by ADHD-HI with ADHD-C being
the least prevalent. This relative distribution of ADHD
presentations was similar for children and adolescents
with the exception that rates of ADHD-HI and ADHD-
C were identical among adolescents. In the United States
study conducted by Gadow and colleagues [17], among
their younger cohort (6–12 years old) both ADHD-I and
ADHD-HI were tied in first place. Among their older
Table 2 Association between ADHD and adverse outcomes
Outcome ADHD-I
aOR;95% CI; P-value
ADHD-HI
aOR;95% CI; P-value
Any ADHD
aOR;95% CI; P-value
Onset of sexual intercourse 3.43 (0.91; 12.92)
P = 0.07
0.87 (0.07; 10.59)
P = 0.92
2.93 (0.86; 9.97)
P = 0.09
Poor academic performance 3.72 (2.02; 6.85)
P < 0.001
1.43 (0.53; 3.82)
P = 0.48
3.85 (2.26; 6.55)
P < 0.001
Any problems at school 1.53 (0.79; 2.94)
P = 0.21
2.11 (0.88; 5.02)
P = 0.09
2.30 (1.35; 3.92)
P = 0.002
Any visit to the health Unit 0.81 (0.30; 2.18)
P = 0.68
0.66 (0.15; 2.99)
P = 0.59
0.70 (0.29; 1.68)
P = 0.43
Hospital Admission Too few cases to model 2.31 (0.29; 18.13)
P = 0.43
0.52 (0.07; 3.91)
P = 0.52
Non-adherence to HIV treatment 1.58 (0.47; 5.28)
P = 0.46
0.56 (0.06; 5.47)
P = 0.62
1.16 (0.37; 3.59)
P = 0.80
NOTE: ADHD attention-deficit/hyperactivity disorder, I inattentive presentation, HI hyperactive-impulsive presentation, C combined presentation, CASI Child and
Adolescent Symptom Inventory
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cohort (13–18 years old), ADHD-I was more common
than ADHD-HI and ADHD-C, rates for which were
identical. Conversely, the South African study by Zeegers
and colleagues [15] found that caregiver ratings indi-
cated ADHD-HI and ADHD-C were the most and least
common, respectively, but teacher assessments of the
same sample indicated ADHD-C was the most frequent
presentation with ADHD-I and ADHD-HI both coming
in second.
In our Uganda study, several clinical correlates were
associated with the different ADHD presentations. In-
creasing age was associated with increased risk for
ADHD-I, which is consistent with the findings from re-
view of literature from nine studies conducted in Africa
[42] and is likely explained by the increasing demands
school curricula as youth grow older. We observed an
increase in the risk of ADHD-I with increasing socio-
economic status whereas previous studies of non-HIV
samples conducted in the West have reported just the
opposite [35, 37]. A possible explanation for our Uganda
finding is that more affluent families are better able to
pay school fees, and the school is arguably the primary
setting in which ADHD-I symptoms are most problem-
atic. In addition, higher socio-economic status is associ-
ated with caregiver educational attainment and greater
sensitivity to their child’s academic success. Consistent
with this interpretation, there was a marginally signifi-
cant association between increasing caregiver educa-
tional status and rates of ADHD-I.
Increasing caregiver psychological distress was associ-
ated with higher rates of all ADHD presentations. Simi-
lar results have previously been reported by others both
among an HIV [2] and a non-HIV [21] population in the
West. Possible explanations suggested by others include
heritability of ADHD (or any other mental health prob-
lems), stressful family and social environments associated
with ADHD (or any other mental health problems), and
the erosion of parenting capacities which often accompany
a parent with HIV or mental illness [2, 21, 43]. In support
of the latter, we found that deteriorating quality of the
child-caregiver relationship (communication style and
emotional reaction between the child and caregiver) was
associated with all three ADHD presentations, which is
consistent with the findings of others for both HIV [43]
and non-HIV [44] samples. Suffering physical abuse (i.e.,
having ever been beaten) was associated with a fivefold
increased risk of ADHD: HI in our adolescent-age sample,
which is in accord with the extant literature [44]. It has
been suggested that ADHD symptoms may illicit feelings
of hostility in the caregiver causing them to use aversive
behaviour management strategies with CA-HIV [44].
Additional variables associated with ADHD were
orphanhood and CD4 counts. Orphanhood, which not
surprisingly was highest among those who reported loss
of both parents, was marginally associated with ADHD-C.
Previous studies among HIV populations have reported
the association between orphanhood and youths’ mental
health [45, 46]. Decreasing CD4 counts were marginally
associated with increase in the odds of ADHD-I, and prior
studies undertaken in the United States report similar
findings [2, 10, 35, 36, 43, 47, 48].
ADHD can have a substantial impact on school func-
tioning and is associated with poor exam performance,
grade retention, and failure to graduate from secondary
school [49]. Cognitive deficits that may interfere with
academic performance have commonly been reported
among CA-HIV [22, 35, 50]. In our Ugandan sample, we
found that any ADHD presentation and ADHD-I specif-
ically were associated with poor academic performance.
In addition, having any ADHD presentation was associ-
ated with problems at school, which is in accord with
prior research involving CA-HIV [2, 35].
Early onset of sexual intercourse (only assessed among
adolescents) was marginally associated (p = 0.07) with a
two- to threefold increase of having any ADHD or
ADHD-I (aORs of 2.93 and 3.43, respectively). Studies
conducted elsewhere have reported a positive association
between ADHD and risky sexual behaviour [21, 23, 35],
which may have important implications for disease
transmission. Although others have reported that among
CA-HIV, co-occurring ADHD is associated with poorer
adherence to HIV treatment, number of hospital visits,
and hospital admissions [43, 50], this was not the case in
our study.
This study has several strengths to include an excep-
tionally large sample of CA-HIV, comprehensive
assessment battery, and cross-cultural orientation,
there are also limitations. Because our analyses are
cross-sectional, we cannot comment on the casual
directions, but these will be addressed in future publi-
cations about the longitudinal component of the
CHAKA study. Since ADHD symptoms are influenced
by environmental variables and therefore different in-
formants can disagree about symptom severity [51],
our prevalence rates for ADHD in Uganda should be
considered conservative estimates as we did not obtain
CASI-5 ratings from our sample’s school teachers.
Because we do not have a comparable sample of sero-
negative youth from the same geographic areas and
environment, it is not possible to know whether rela-
tions between ADHD and putative mental health
factors and functional outcomes are influenced by
HIV status. This does not, however, detract from the
clinical implications of our findings for CA-HIV. By
design, the present study focused on CA-HIV living in
Uganda, and owing to considerable cultural variation
in East Africa, our results may not generalize to other
countries in the region.
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Conclusions
In summary, approximately 6% of CA-HIV living in
Uganda met DSM-5 symptom count criteria for ADHD.
Clinical ccorrelates of ADHD were reported for all do-
mains (general socio-demographic, caregiver, psychosocial
environmental and HIV illness). ADHD among CA-HIV
was associated with poorer academic performance, school
disciplinary problems, and earlier age of onset of sexual
intercourse, all of which may have important implications
for clinical management, quality of life, long-term out-
come and possible disease transmission. Moving forward,
there is a definite need to integrate mental health services
into routine HIV care to include the development of cost-
effective assessment and treatment strategies that have
high probability of success in challenging intervention
settings.
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